CVS Health, a New England Council member, has teamed up with Boston Medical Center (BMC) and Rhode Island Hospital to conduct a study on effective distribution of Narcan in pharmacies throughout Massachusetts and Rhode Island.
Narcan, or Naloxone, is the antidote for an opioid overdose. The study will focus on the use of naloxone rescue kits which can be used to prevent overdose deaths throughout the two states. The goal of the study is to discover best practices for the distribution of Narcan. In order to finance this study, BMC was awarded a $1.3 million grant from the Agency for Healthcare Research and Quality.
CVS Health Chief Scientific Officer William Shrank, MD, said, “CVS Health has a long-standing commitment to prevent prescription drug abuse and our participation in this demonstration project complements our ongoing efforts to expand the availability and distribution of naloxone to prevent opioid overdoses. All of our CVS/pharmacy locations in Rhode Island and Massachusetts keep naloxone in stock and it is available without a prescription. In addition, by the end of this month, CVS/pharmacy will be able to dispense naloxone without a prescription in 14 additional states.”
The New England Council commends CVS for their role in helping to fight the opioid overdose epidemic in New England and throughout the country.
For more information about the study, see the CVS Health press release or this Boston Heraldarticle.